ASND N logo

Ascendis Pharma BMV:ASND N Stock Report

Last Price

Mex$2.56k

Market Cap

Mex$150.9b

7D

0%

1Y

n/a

Updated

21 Nov, 2024

Data

Company Financials +

ASND N Stock Overview

A biopharmaceutical company, focuses on developing therapies for unmet medical needs. More details

ASND N fundamental analysis
Snowflake Score
Valuation3/6
Future Growth5/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Ascendis Pharma A/S Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ascendis Pharma
Historical stock prices
Current Share PriceUS$2,559.00
52 Week HighUS$2,559.00
52 Week LowUS$2,090.00
Beta0.65
11 Month Changen/a
3 Month Changen/a
1 Year Changen/a
33 Year Change-17.59%
5 Year Changen/a
Change since IPO274.12%

Recent News & Updates

Recent updates

Shareholder Returns

ASND NMX BiotechsMX Market
7D0%0%0%
1Yn/a0%0%

Return vs Industry: Insufficient data to determine how ASND N performed against the MX Biotechs industry.

Return vs Market: Insufficient data to determine how ASND N performed against the MX Market.

Price Volatility

Is ASND N's price volatile compared to industry and market?
ASND N volatility
ASND N Average Weekly Movementn/a
Biotechs Industry Average Movement0%
Market Average Movement0%
10% most volatile stocks in MX Market0%
10% least volatile stocks in MX Market0%

Stable Share Price: ASND N's share price has been volatile over the past 3 months compared to the MX market.

Volatility Over Time: Insufficient data to determine ASND N's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006879Jan Mikkelsenascendispharma.com

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

Ascendis Pharma A/S Fundamentals Summary

How do Ascendis Pharma's earnings and revenue compare to its market cap?
ASND N fundamental statistics
Market capMex$150.90b
Earnings (TTM)-Mex$9.13b
Revenue (TTM)Mex$7.01b

21.5x

P/S Ratio

-16.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ASND N income statement (TTM)
Revenue€327.43m
Cost of Revenue€49.69m
Gross Profit€277.74m
Other Expenses€704.23m
Earnings-€426.49m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-7.14
Gross Margin84.82%
Net Profit Margin-130.26%
Debt/Equity Ratio-810.4%

How did ASND N perform over the long term?

See historical performance and comparison